Investment
Features
FeesSafety
Academy
More
Pluang+

Jerash Holdings posts strong Q1 FY2027 with 26.7% revenue growth and EPS beating estimates.

Company Fundamentals
11 Aug 2026
Andrew Wynn
View Source
Bullish
pluang ai news

Jerash Holdings reported a strong Q1 FY2027, with revenue rising 26.7% year-over-year to $50.23 million, driven by increased shipments to U.S. customers. Earnings per share came in at $0.13, surpassing analyst estimates of $0.10. Profitability improved significantly, with gross profit up 35.7% and operating income soaring 174.4%. The company maintains a strong liquidity position and low debt, signaling robust financial health moving forward.

More News

TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental posts 118% revenue growth and beats EPS estimates despite ongoing losses

TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...

Company Fundamentals
Bullish
43 minutes ago
Madison Square Garden Sports price target raised on strong Q4 results and Knicks' NBA win

Madison Square Garden Sports price target raised on strong Q4 results and Knicks' NBA win

Seaport Global raised the price target for Madison Square Garden Sports Corp. to $473, reflecting a 17.13% potential upside. The company reported strong fiscal Q4 results with earnings per share of $1.19, beating estimates of $0.72, and revenue risin...

Company Fundamentals
Bullish
1 hour ago
Airbus leads aerospace market with strong orders despite production challenges

Airbus leads aerospace market with strong orders despite production challenges

Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...

Market News
Bullish
1 hour ago
PAVmed reports Q2 loss narrower than expected, revenue below estimates, plans FDA submission in 2027

PAVmed reports Q2 loss narrower than expected, revenue below estimates, plans FDA submission in 2027

PAVmed reported a Q2 2026 GAAP loss per share of $0.87 and a non-GAAP loss of $0.27, beating analyst expectations of a $0.47 loss. Revenue was $33,000, below the $49,000 consensus. Lucid Diagnostics, an investment of PAVmed, generated $1.5 million in...

Company Fundamentals
Bearish
1 hour ago
Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.

Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.

Target is expected to report second-quarter earnings of $2.25 per share, a 9.8% increase from last year, with revenues projected at $26.06 billion, up 3.4%. Despite these positive forecasts, the stock has surged 57% year-to-date, leading an analyst t...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App